AA
OKTA icon

Altrafin AG’s Okta OKTA Stock Holding History

Altrafin AG’s Portfolio OKTA Stock Details OKTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3M Buy
21,970
+12,970
+144% +$1.22M 1.17% 26
2026
Q1 		$708K Buy
+9,000
New +$747K 0.24% 40

Other funds holding OKTA

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BIM
Barton Investment Management West Conshohocken, Pennsylvania $738M AUM 7.58% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

Altrafin AG's OKTA Position: Q2 2026 in Review

Altrafin AG increased its Okta (OKTA) stake by 144% in Q2 2026, buying an estimated $1.22M and bringing the position to 21,970 shares worth $3M. The position accounts for 1.17% of the portfolio, ranked #26.

Altrafin AG first reported a position in OKTA in Q1 2026 and has held it in 2 quarters since. 110 funds tracked by Wall St. Rank hold OKTA as of Q2 2026.

  • Altrafin AG held 21,970 shares of Okta worth $3M as of Q2 2026.
  • Altrafin AG bought 12,970 Okta shares in Q2 2026, an estimated $1.22M.
  • Okta made up 1.17% of Altrafin AG's portfolio in Q2 2026, its #26 holding.
  • Altrafin AG first reported a position in Okta in Q1 2026 and has held it in 2 quarters since.
  • 110 funds tracked by Wall St. Rank held Okta as of Q2 2026.

Based on Altrafin AG's 13F filing for Q2 2026, filed 15 Jul 2026.